English  |  正體中文  |  简体中文  |  Total items :2851816  
Visitors :  44934052    Online Users :  1418
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"rapatoni l"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 1-2 of 2  (1 Page(s) Totally)
1 
View [10|25|50] records per page

Institution Date Title Author
國家衛生研究院 2025-01-27 Updated results from the trastuzumab deruxtecan (T-DXd) 5.4 mg/kg triplet combination of DESTINY-Gastric03 (DG-03): First-line (1L) T-DXd with fluoropyrimidine (FP) and pembrolizumab in advanced/metastatic HER2-positive (HER2+) esophageal adenocarcinoma, Janjigian, YY;Van Laarhoven, HWM;Rha, SY;Kozlov, V;Oh, D;Gravina, A;Rapatoni, L;Shoji, H;Hofheinz, RD;Chen, LT;Ford, H;Chenard-Poirier, M;de Giorgio-Miller, V;Chang, YT;Anadu, O;Lee, J
國家衛生研究院 2024-09 Trastuzumab deruxtecan (T-DXd) monotherapy and combinations in patients (pts) with advanced/metastatic HER2-positive (HER2+) esophageal, gastric or gastroesophageal junction adenocarcinoma (GEJA): DESTINY-Gastric03 (DG-03) Janjigian, YY;van Laarhoven, HWM;Rha, SY;Kozlov, V;Oh, DY;Gravina, A;Rapatoni, L;Shoji, H;Hofheinz, RD;Chen, LT;Ford, HER;Chenard-Poirier, M;Raoufmoghaddam, S;Lloyd, C;Zhang, C;Mateo, C;Lee, J

Showing items 1-2 of 2  (1 Page(s) Totally)
1 
View [10|25|50] records per page